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Divergent Pharmacological Properties of SCN1A Splice Variants
Christopher H. Thompson, Kristopher M. Kahlig, Alfred L. George Jr.
Vanderbilt University, Nashville, TN, USA.
Voltage-gated sodium channels undergo alternative mRNA splicing. In the
human neuronal Nav1.1 channel encoded by SCN1A, a common genetic vari-
ant affecting an intron splice donor site alters the proportion of transcripts that
incorporate the canonical exon 5 (exon 5A) or an alternative (exon 5N) encod-
ing portions of the S3 and S4 segments of domain 1. Epileptic subjects with this
genetic variant require lower doses of anticonvulsant drugs such as phenytoin
compared with individuals lacking this variant. Because this genetic variant is
associated with a larger proportion of exon 5N containing transcripts in brain,
we hypothesized that differences in function and pharmacology of Nav1.1
channels containing either exon 5N or 5A account for the observed divergence
in anticonvulsant dose requirements. To examine differences in drug efficacy of
SCN1Asplice variants,we performedwhole-cell recording on tsA201 cells tran-
siently co-transfected with either Nav1.1-5A or Nav1.1-5N and two accessory
subunits (b1,b2). We examined voltage-dependence of activation, steady-state
inactivation, and recovery from fast inactivation and observed no significant
differences between splice variants. We also measured both steady-state block
and use-dependent block (10Hz) by phenytoin, carbamazepine, and lamotrigine.
Nav1.1-5N channels exhibited greater steady-state block by phenytoin(100mM)
(1655% vs. 256%) and lamotrigine(200mM) (2554% vs. 1452%) compared
to Nav1.1-5A. Additionally, Nav1.1-5N exhibited greater use-dependent block
by phenytoin (3955% vs. 2454%) and lamotrigine (2956% vs. 1852%).We
tested cells stably transfected with either Nav1.1-5A or Nav1.1-5N and both
b subunits using an automated planar patch clamp system (Patchliner, Nanion
Inc.) to perform concentration-response curves to determine steady-state and
inactivated state affinities for lamotrigine. Similar to conventional patch clamp
experiments, lamotrigine exhibited greater steady-state and inactivated state
affinity for Nav1.1-5N than Nav1.1-5A. These results suggest SCN1A tran-
scripts containing the alternative exon 5N encode channels that are more sensi-
tive to multiple anticonvulsant drugs.
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From Plastic-Bottle-Toxin to Sodium Channel Blocker: A New Role for Bi-
sphenol A
Angelika Lampert1,2, Andrias O. O’Reilly3, B. A. Wallace3,
Christian Alzheimer1,2.
1FAU Erlangen, Erlangen, Germany, 2Univ. of Kiel, Physiology, Kiel,
Germany, 3Univ. of London, Dept. Crystallography, London, United
Kingdom.
BisphenolAhas reached public attentiondue to its presence in foodandbeverages
following leaching fromplastic containers.. It is amonomer that is polymerized to
manufacture polycarbonate plastic food wrappings and it is detectable in the
blood of human populations in developed countries (Palanza et al. 2008, Environ-
mental Research). In animal studies and in vitro bisphenol A was shown to have
estrogenic effects. Data link bisphenol A exposure to a variety of diseases
including miscarriage, menstrual pain and cardiovascular syndromes.
The human heart voltage-gated sodium channel hNav1.5 was expressed in
HEK293t cells to determine the effect of bisphenol A on sodium channel
function.
With whole-cell patch clamp analysis, we show that bisphenol A reduces the
peak sodium current through hNav1.5 from a holding potential of 120 mV
with an EC50 of 54 5 8 mM This concentration is considerably higher than
has been found in beverages from plastic bottles. However, compared to other
known sodium channel blockers, such as lamotrigine or lidocaine, its efficacy is
approximately ten-fold higher.
Bisphenol A shifts steady-state fast inactivation to more hyperpolarized poten-
tials, whereas voltage-dependence of activation is unaffected. As with local
anesthetics, bisphenol A binds preferentially to the inactivated state. The asso-
ciation time constant, as determined by a single exponential fit of peak current
decline induced by 30 mM bisphenol A is approximately 14 times faster than
that induced by 300 mM lidocaine.
In conclusion, we have determined that bisphenol A has blocking effects on
hNav1.5 sodium currents that are more pronounced than those of known
blockers, such as lidocaine or lamotrigine.
Funding: AOR and BAW: BBSRC. AL: Robert-Bosch-Foundation.
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Characterization of the Reverse Use Dependent Block of Voltage Gated
Sodium Channels
Caterina Virginio, Elisa Ballini, Laura Aldegheri, Laura Castelletti,
AnnaMaria Capelli, Wolfgang Jarolimek.
GlaxoSmithKline, Verona, Italy.Some clinically used drugs interact via state-dependent inhibition of voltage-
gated sodium channels. For example, cocaine, procaine or lidocaine preferen-
tially interact with, and stabilize the inactivated conformation of the channel.
Upon repetitive high frequency activation they cause a progressive inhibition
during the pulse train which is termed use-dependent inhibition.
Here we describe compounds that show the opposite behaviour, ie the inhibi-
tion is diminished during the pulse train.
To adequately determine the state-dependent interactions of drugs with sodium
channels, we developed a high-throughput electrophysiological assay using the
IonWorks(r) Quattro(tm) PPC platform. Compounds were tested against the
brain Nav1.3 sodium channel expressed in CHO cells. A train of 10 depolariz-
ing voltage steps from90mV to 0mV for 20ms (10Hz frequency) was applied
before and after compound addition. To evaluate the tonic block, inhibition of
the peak current at the first pulse was measured while the use-dependent block
was determined as the inhibition at the 10th pulse. Lidocaine shows the ex-
pected use-dependent inhibition. Surprisingly, we found compounds with the
opposite profile: the compound with the most pronounced effect blocked the
1st and 10th pulses by 72.356.1 % and 42.956.9 % (mean5SD, n¼5) at
10uM. In a second instance these compounds were tested against the cardiac
Nav1.5 and the peripheral nervous and neuroendocrine systems Nav1.7 observ-
ing similar effects. An in-depth comparison between use-dependent and reverse
use-dependent blockers was performed for parameters such as voltage-depen-
dent activation and inactivation, recovery from inactivation, and frequency
dependency. These data provide biophysical insights in the mechanism of
reverse use-dependent inhibition for Nav channels.
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Insights on the Mechanisms of the Fast Blockade of TTX-R Naþ Channels
by Eugenol
Joa˜o L. Carvalho-de-Souza, Antonio Carlos Cassola.
University of Sa˜o Paulo, Sa˜o Paulo, Brazil.
OBJECTIVES. It was previously shown that eugenol, a phenylpropene, blocks
fast and reversibly voltage-gated Naþ channels (NaV), but little concern was
given to the blocker binding to different conformational states of channel mol-
ecule. Here we reported a detailed analysis of state-dependent effects of euge-
nol on tetrodotoxin-resistant (TTX-R) NaV isoforms, comparing them to those
of lidocaine, a reference blocker.
METHODS. TTX-R Naþ currents were recorded in dorsal root ganglia neu-
rons from newborn Wistar rats with whole-cell configuration of patch clamp
technique. Tetrodotoxin-sensitive Naþ currents were blocked by TTX 100nM
in the extracellular solution.
RESULTS and CONCLUSIONS. A dose-dependent fast blockade due to eu-
genol was observed in 0.2Hz time series depolarizations from a holding po-
tential of 110 mV to a 0 mV pulse. This tonic blockage is due to eugenol
binding to the closed state. The IC50 was 2.2850.10mM for eugenol com-
pared to 0.4450.08mM for lidocaine. The tonic NaV blockade was more ef-
fective when the membrane was held at more depolarized, still sublimiar,
holding potentials. This observation indicates a higher affinity of eugenol
for closed substates dwelled at less hyperpolarized potentials. No consistent
evidences for additional binding to open state were observed. A displacement
of steady-state inactivation curve to more negative potentials, associated with
a slower recovery from fast inactivation under eugenol indicates that this
molecule also binds to fast inactivated state. For currents undergoing slow in-
activation, a consistent reduction by eugenol indicates that the phenylpropene
additionally binds to the slow inactivated state. A frequency-dependent block-
ing effect of eugenol on NaV was observed, but the effect is smaller than that
induced by lidocaine. In conclusion, eugenol binds to several isoforms of
TTX-R NaV and to the different states of the proteins, leading to a channel
blockage.
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A Residue (W756) in the P-Loop Segment of Sodium Channel is Critical
for Primaquine Binding
Eduardo M. Salinas1, Evelyn Martinez-Morales1,
Lourdes Millan-PerezPen˜a2, Thomas F. Scior3.
1Instituto de Fisiologia-BUAP, Puebla, Mexico, 2Centro de Quimica-BUAP,
Puebla, Mexico, 3Facultad de Ciencias Quimicas-BUAP, Puebla, Mexico.
The scope of our study on wild-type and mutant-types of the voltage-dependent
sodium channel in rat skeletal muscle (Nav 1.4) was to examine the possible
binding site of primaquine (PQ) using a combined design and experimental ap-
proach. We applied a standard voltage-clamp in oocytes and in-silico methods,
mainly protein modeling and ligand docking. Previously, we demonstrate that
PQ blocks the voltage-dependent sodium current in rat myocytes, and these
block is concentration-dependent and voltage-independent fashion. Direct site
mutagenesis in the P-loop segment (W756C, W1239C and W1531A at the
Sunday, February 21, 2010 115aouter tryptophan-rich lip, as well as D400C, E758C, K1237C and A1529C of
the DEKA locus) helped us to identify residues playing a key role in aminoqui-
noline binding. In full agreement with our computed results, tryptophan W756
is crucial for the reversible blocking effects of PQ. W756C abolished the block-
ing effect of PQ in voltage-clamp assays.
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Defining the Voltage Sensor Properties and Pharmacology of Nav1.9
Frank Bosmans1, Michelino Puopolo2, Marie-France Martin-Eauclaire3,
Bruce P. Bean2, Kenton J. Swartz1.
1NIH, Bethesda, MD, USA, 2Harvard Medical School, Boston, MA, USA,
3CNRS, Marseille, France.
The voltage-activated sodium channel Nav1.9 is preferentially expressed in
DRG neurons where it is believed to play an important role in pain perception.
However, progress in revealing the gating characteristics and pharmacological
sensitivities of Nav1.9 has been slow because attempts to express this channel
in a heterologous expression system have been unsuccessful. Here we use a pro-
tein engineering approach to study the contributions of the four Nav1.9 voltage
sensors to channel function. We define individual S3b-S4 paddle motifs within
each voltage sensor and show that these structural motifs sense changes in
membrane voltage and determine the kinetics of voltage sensor activation.
Toxins from tarantula and scorpion venom interact with each of these four mo-
tifs and can be used as pharmacological tools to alter Nav1.9 currents in native
DRG neurons. Our results provide answers to fundamental questions on the
functional role of the four voltage sensors in Nav1.9 and may be useful in
developing new strategies to combat pain.Voltage-gated K Channels-Permeation
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KcsA Barium Permeation Blocked by External Potassium
Kene N. Piasta, Christopher Miller.
Brandeis University, Waltham, MA, USA.
Block by Ba2þ is a distinctive property of Kþ channels, and in a few cases this
block can be used as a tool to determine the affinity for various ions at specific
sites in the selectivity filter. We measure the discrete block of single E71A
KcsA channels, a non-inactivating mutant, with micromolar concentrations
of internal Ba2þ and find at high concentrations of external Kþ the block
time distribution is described by a double exponential. This suggests there
are two Ba2þ sites in the selectivity filter, fitting well with the published
Ba2þ containing structure of KcsA where a Ba2þ ion resides approximately
in S2 and S4. Utilizing a kinetic analysis of the blocking events, we can deter-
mine the occupancy of Kþ and other cationic monovalent ions in an extracel-
lular site, presumably S1, and thus determine selectivity for this particular site.
Our kinetic data has shown KcsA has an unusually high selectivity for Kþ over
Naþ with a ddG0 of 5.6 kcal mol1.
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The Role Of Oligo-(R)-3-Hydroxybutyrates in the Streptomyces lividans
KcsA Channel
Alexander Negoda, Elena Negoda, Rosetta N. Reusch.
Michigan State University, East Lansing, MI, USA.
The Streptomyces lividans potassium channel KcsA is a tetramer of four poly-
peptides, each covalently modified by oligo-(R)-3-hydroxybutyrate (cOHB),
which envelop a core molecule of inorganic polyphosphate (polyP). It has
been proposed that the polyanion, polyP, attracts, binds and conducts Kþ in re-
sponse to an electrochemical stimulus whilst the polypeptides govern access to
polyP and regulate its selectivity. The function of cOHB, however, has been
undefined.Digestion of KcsA with CNBr yields a 6.7 kDa fragment that con-
tains most of the ion pathway (residues 97-154). This fragment was shown to
contain cOHB by Western blot and chemical assays. The conjugation sites
for cOHB were determined to be on S102 and S129. The effects of the single
mutations S102, S129 and the double mutation S102:S129 on channel activity
were examined. Wild-type KcsA, incorporated into planar lipid bilayers of
POPC:POPE:POPG (3:3:1) between aqueous solution of 200 mM KCl,
5 mM MgCl2, 20 mM Hepes, pH 7.4 cis and 20 mM KCl, 5 mM MgCl2,
20 mM Hepes, pH 7.4 trans forms well-structured channels of 147 pS conduc-
tance. Under the same conditions, S102G exhibits irregular conductance with
a major conductance state of 75 pS and a minor conductance state of 103 pS,
S129G exhibits frequent but unsuccessful attempts to insert into the bilayer,
and S102:S129 exhibits no channel activity whatsoever. The results suggest
that cOHB-modification of KcsA polypeptides is essential for normal channel
function.603-Pos
Potassium Channel Block by a Tripartite Complex of Neutral Ligands with
a Potassium Ion
Pavel I. Zimin1, Bojan Garic2, Heike Wulff1, Boris S. Zhorov2.
1UC Davis, Davis, CA, USA, 2McMaster University, Hamilton, ON, Canada.
Potassium channels are targets for medically important drugs of large chemical
diversity. While classical hydrophilic cations like tetraethylammonium block
Kv channels with a stoichiometry of 1:1, many uncharged lipophilic (neutral)
compounds exhibit Hill coefficients of 2. An example is the alkoxypsoralen
PAP-1, which blocks Kv1.3 channels in lymphocytes with an IC50 of 2 nM
and constitutes a potential drug for autoimmune disease such as type-1 diabe-
tes, multiple sclerosis, rheumatoid arthritis, and psoriasis. The atomic mecha-
nism of Kv channel block by ligands like PAP-1 is unknown. We first studied
structure-activity relationships of PAP-1 derivatives and found that the car-
bonyl group in PAP-1’s coumarin ring is indispensable, but does not accept
an H-bond from the channel. We next demonstrated that block by PAP-1 is
voltage-dependent, a feature expected for cationic but not neutral ligands.
We then employed molecular modeling to predict the PAP-1 receptor and
arrived at a model in which the carbonyl groups of two PAP-1 molecules
coordinate a potassium ion in the permeation pathway, while the hydrophobic
phenoxyalkoxy side-chains extend into the intrasubunit interfaces between
helices S5 and S6 and reach the L45 linker. We tested the model by generating
58 point mutants involving residues in and around the predicted receptor, and
then determined their biophysical properties and sensitivity to block by PAP-1.
We found excellent agreement between the atomistic model and the results of
experimental studies. Besides the known drug-binding locus in the inner pore,
which is rather conserved between different Kv channels, the PAP-1 receptor
involves loci where sequence homology is low. These loci constitute attractive
targets for the design of subtype-specific potassium channel drugs and offer
new directions for structure-based drug design.
Supported by NSERC, CIHR, NIH, and HHMI.
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Effect of Peptide Toxins on C-Type Inactivation of a Mutant Human
Voltge-Gated Potassium Channel (hKv1.3)
Azadeh Nikouee Ghadikolaei, Stephan Grissmer.
Institute of Applied Physiology, Ulm, Germany.
Current through wt hKv1.3channels is characterized by the typical C-type in-
activation and the high affinity block by scorpion peptide toxins. These toxins
belong to a short peptide toxin family with high similarities in 3D shape and
sequence and are thought to block current through hKv1.3 channels by interact-
ing with the outer vestibule of the channel thereby physically occluding the
channel pore. In this study we measured current through hKv1.3_V388C
mutant channels, which inactivated faster compared to the wt channels and
recovery from inactivation was also slower. In our experiments we examined
the effect of CTX, NTX, KTX, AgTX2 and MgTX, each at a concentration
of 100 nM, on current through mutant channels. KTX and AgTX2 did not or
hardly block peak current through the mutant channel at 100 nM, respectively,
indicating a loss of affinity by a factor of>100 due to the mutation in the chan-
nel. In addition, KTX and AgTX2 did not change the inactivation time course
of the current through the mutant channels. In contrast, MgTX, even at a con-
centration of 10 nM, almost completely blocked peak current, indicating sim-
ilar affinities of MgTX to mutant and wt channels. Interestingly, CTX and NTX
did not block peak current through the mutant channels, however, almost com-
pletely abolished inactivation. This is different from the effect of TEA that is
known to prevent inactivation while blocking current through the channel.
We conclude that CTX and NTX bind to the external vestibule of the channel
thereby preventing structural rearrangements of the outer vestibule that nor-
mally occur when channels inactivate.
This work was supported by a grant from the Deutsche Forschugsgemeinschaft
(Gr848/14-1).
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Alprenolol Inhibits Herg Potassium Channels
Seung Ho Lee, Hyang Mi Lee, Bok Hee Choi.
Chonbuk National University Medical School, Jeonju, Republic of Korea.
The action of alprenolol, a non-selective beta blocker as well as 5-HT receptor
antagonist, on the cloned cardiac human ether-a-go-go-related gene (HERG)
channels was investigated using the whole-cell patch-clamp technique. Alpre-
nolol reduced HERG whole-cell currents in a reversible concentration-depen-
dent manner, with an IC50 value and a Hill coefficient of 12.3 5 0.8 ˛1/4M
and 0.985 0.06, respectively. Alprenolol affected the channels in the activated
and inactivated states but not in the closed states. The alprenolol-induced
blockade of HERG was found to be use-dependent, exhibiting a more rapid on-
set and a greater steady-state block at the higher frequencies of activation.
